These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15844228)

  • 1. Resistance with short-course nevirapine.
    AIDS Patient Care STDS; 2005 Mar; 19(3):202. PubMed ID: 15844228
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmission of human immunodeficiency virus type 1 nevirapine resistance mutation K103N from a treatment-naive mother to her child.
    Schmitz T; Kleinkauf N; Klempa B; Ringe H; Varnholt V; Grosch-Wörner I
    Pediatr Infect Dis J; 2006 Mar; 25(3):275-6. PubMed ID: 16511398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nevirapine: a new principle of action against HIV].
    Dtsch Med Wochenschr; 1996 Dec; 121(49):A48-9. PubMed ID: 8998915
    [No Abstract]   [Full Text] [Related]  

  • 4. Nevirapine may promote resistance.
    AIDS Patient Care STDS; 2004 Apr; 18(4):249-50. PubMed ID: 15154406
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments by Global Strategies for HIV Prevention on nevirapine resistance.
    GMHC Treat Issues; 2004; 18(11-12):15. PubMed ID: 15751140
    [No Abstract]   [Full Text] [Related]  

  • 6. Selection of resistance mutations in children receiving prophylaxis with lamivudine or nevirapine for the prevention of postnatal transmission of HIV.
    Giuliano M; Galluzzo CM; Germinario EA; Amici R; Bassani L; Dehò L; Vyankandondera J; Mmiro F; Okong P; Vella S
    J Acquir Immune Defic Syndr; 2006 May; 42(1):131-3. PubMed ID: 16763503
    [No Abstract]   [Full Text] [Related]  

  • 7. Nevirapine (Viramune).
    Res Initiat Treat Action; 2000 Mar; 6(1):18-9. PubMed ID: 11708179
    [No Abstract]   [Full Text] [Related]  

  • 8. Which ART regimen is best after receipt of single-dose nevirapine?
    Ryan CT
    AIDS Clin Care; 2009 Jan; 21(1):6. PubMed ID: 19230057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.
    Martinson NA; Morris L; Johnson J; Gray GE; Pillay V; Ledwaba J; Dhlamini P; Cohen S; Puren A; Steyn J; Heneine W; McIntyre JA
    AIDS; 2009 Apr; 23(7):809-16. PubMed ID: 19287298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevirapine-related death draws attention.
    AIDS Patient Care STDS; 2005 Mar; 19(3):202. PubMed ID: 15841567
    [No Abstract]   [Full Text] [Related]  

  • 11. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
    Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Piyavong B; Chumpathat N; Chantratita W
    Clin Infect Dis; 2007 Feb; 44(3):447-52. PubMed ID: 17205457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state nevirapine plasma concentrations are influenced by pregnancy.
    Nellen JF; Damming M; Godfried MH; Boer K; van der Ende ME; Burger DM; de Wolf F; Wit FW; Prins JM
    HIV Med; 2008 Apr; 9(4):234-8. PubMed ID: 18366447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nevirapine toxicity.
    Taiwo BO
    Int J STD AIDS; 2006 Jun; 17(6):364-9; quiz 370. PubMed ID: 16734954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IOM: nevirapine study is reliable.
    James JS
    AIDS Treat News; 2005 Mar; (411):6. PubMed ID: 15906454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Averting drug resistance while preventing MTCT.
    AIDS Read; 2005 Apr; 15(4):150-1. PubMed ID: 15846848
    [No Abstract]   [Full Text] [Related]  

  • 16. Nevirapine concentration in cervicovaginal and oropharyngeal secretions after single-dose administration to the mother.
    Harms G; Kunz A; Karcher H; Mugenyi K; Kurowski M
    Antivir Ther; 2005; 10(6):777. PubMed ID: 16218178
    [No Abstract]   [Full Text] [Related]  

  • 17. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
    Koh MT
    Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J; Yue J; Wu S; Yan Y
    Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-trimester maternal toxicity with nevirapine use in pregnancy.
    Joy S; Poi M; Hughes L; Brady MT; Koletar SL; Para MF; Fan-Havard P
    Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1032-8. PubMed ID: 16260522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose nevirapine to prevent mother-to-child transmission of HIV type 1: balancing the benefits and risks.
    Mellors JW; Chow JY
    Clin Infect Dis; 2009 Feb; 48(4):473-5. PubMed ID: 19133800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.